Medicare Enrolled
Dr. Nithi Anand, MD
Neurology · Marietta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Anand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anand
Dr. Nithi Anand is a neurology specialist in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Anand performed 18,814 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Anand received a total of $75,149 from 73 pharmaceutical and/or device companies across 759 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in GA
$75,149 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗18,814
Medicare services
Top 4% in GA for neurology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
18,000 | $5 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
236 | $89 | $281 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
184 | $55 | $198 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
92 | $124 | $404 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $114 | $375 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
71 | $42 | $142 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
54 | $164 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
34 | $81 | $249 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
25 | $41 | $142 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
22 | $75 | $244 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
17 | $106 | $281 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$75,149
Total received (2018-2024)
Avg $10,736/year across 7 years
Top 7% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
759
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,381
2023
$7,405
2022
$9,260
2021
$17,302
2020
$24,541
2019
$12,451
2018
$2,808
Payments by company (2024)
ABBVIE INC.
$405
Celgene Corporation
$185
PFIZER INC.
$145
UCB, Inc.
$135
ACADIA Pharmaceuticals Inc
$70
Amgen Inc.
$68
Otsuka America Pharmaceutical, Inc.
$58
Teva Pharmaceuticals USA, Inc.
$58
Sumitomo Pharma America, Inc.
$52
Lilly USA, LLC
$33
GE HEALTHCARE
$33
Averitas Pharma Inc.
$28
Eisai Inc.
$19
Octapharma USA, Inc.
$17
Novartis Pharmaceuticals Corporation
$16
SCILEX PHARMACEUTICALS INC.
$16
Acorda Therapeutics, Inc
$16
Alexion Pharmaceuticals, Inc.
$15
Biogen, Inc.
$13
Top 3 companies account for 53.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$24,854
Allergan, Inc.
$19,664
AbbVie Inc.
$12,305
ABBVIE INC.
$4,213
Lilly USA, LLC
$2,439
Biohaven Pharmaceutical Holding Company Ltd.
$1,746
Lundbeck LLC
$1,464
Teva Pharmaceuticals USA, Inc.
$574
Novartis Pharmaceuticals Corporation
$533
UCB, Inc.
$521
Supernus Pharmaceuticals, Inc.
$491
ACADIA Pharmaceuticals Inc
$483
Biogen, Inc.
$424
EMD Serono, Inc.
$407
Celgene Corporation
$363
Alexion Pharmaceuticals, Inc.
$335
Sunovion Pharmaceuticals Inc.
$302
CSL Behring
$267
Allergan Inc.
$261
GENZYME CORPORATION
$256
PFIZER INC.
$228
GE HEALTHCARE
$196
GE Healthcare
$189
Acorda Therapeutics, Inc
$186
Otsuka America Pharmaceutical, Inc.
$130
Grifols USA, LLC
$129
Harmony Biosciences LLC
$121
JAZZ PHARMACEUTICALS INC.
$120
Promius Pharma LLC
$115
Biohaven Pharmaceuticals, Inc.
$104
Upsher-Smith Laboratories LLC
$99
Sumitomo Pharma America, Inc.
$97
UPSHER-SMITH LABORATORIES LLC
$84
Bausch Health US, LLC
$80
Avanir Pharmaceuticals, Inc.
$76
Neurocrine Biosciences, Inc.
$74
EISAI INC.
$67
Horizon Therapeutics plc
$63
Amneal Pharmaceuticals LLC
$58
E.R. Squibb & Sons, L.L.C.
$57
AbbVie, Inc.
$56
W. L. Gore & Associates, Inc.
$55
US WorldMeds, LLC
$54
Octapharma USA, Inc.
$51
Eisai Inc.
$45
Janssen Pharmaceuticals, Inc
$42
ARGENX US, INC.
$39
Genentech USA, Inc.
$37
Mallinckrodt Enterprises LLC
$35
Mallinckrodt LLC
$33
Mylan Pharmaceuticals Inc.
$32
Avion Pharmaceuticals
$32
ASSERTIO THERAPEUTICS, Inc.
$29
Egalet US Inc
$28
Averitas Pharma Inc.
$28
Impax Laboratories, Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$26
GE HealthCare
$26
Arbor Pharmaceuticals, Inc.
$26
Greenwich Biosciences, Inc.
$25
IMPEL PHARMACEUTICALS INC.
$24
SANOFI-AVENTIS U.S. LLC
$24
Medtronic USA, Inc.
$24
BANNER LIFE SCIENCES, LLC
$23
TG THERAPEUTICS, INC.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Azurity Pharmaceuticals, Inc.
$18
Ipsen Biopharmaceuticals, Inc
$17
SCILEX PHARMACEUTICALS INC.
$16
Assertio Therapeutics, Inc.
$16
Abbott Laboratories
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
Aprecia Pharmaceuticals, LLC
$12
Top 3 companies account for 75.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Epidiolex · Fintepla · Fycompa · GILENYA · GORE CARDIOFORM Septal Occluder · Gamunex-C · Glatiramer Acetate · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RESTORE · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SPINRAZA · SPRIX · Soliris · Solitaire · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VRAYLAR · VYEPTI · VYVGART · WAKIX · Wakix · XYREM · XYWAV · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
219
County median income
$98,712
Nearest hospital to ZIP centroid (approximate)
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Anand is a mixed practice specialist, with above-average Medicare volume (top 4% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Anand experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Anand performed 18,000 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Anand receive payments from pharmaceutical companies?
Yes. Dr. Anand received a total of $75,149 from 73 companies across 759 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anand's costs compare to other neurologists in Marietta?
Dr. Anand's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Marietta
Browse neurologists in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology